Google DeepMind Unveils AlphaGenome to Decode Genetic Disease Drivers

Google DeepMind launched AlphaGenome, an AI tool that identifies genetic mutations driving disease.
AlphaGenome predicts how DNA changes disrupt gene regulation across cells and tissues.
The tool analyses up to one million DNA letters at once.
Researchers trained it on human and mouse genetic databases.
Scientists link many diseases to regulatory mutations rather than protein-coding genes.
AlphaGenome helps pinpoint mutations behind cancer, heart disease, and autoimmune disorders.
Experts say it could accelerate drug discovery and gene therapy design.
Researchers at University College London and University of Exeter called it a major advance.